State to invest $2 million in the Blumberg Institute's Angel Investments <<Click here>>

About James Shorter, PhD

James Shorter, PhD

James shorter

Dr. James Shorter graduated with distinction in biology from Keble College, University of Oxford in 1995. He received his PhD from University College London in 2000. After postdoctoral studies at Yale and MIT, James established his own group at the University of Pennsylvania. In 2018, James became Professor of biochemistry and biophysics. In the same year he became a member of the editorial advisory panel for The Biochemical Journal and won a NIH Director’s New Innovator Award. He has been recognized by several other prestigious awards, including Ellison Medical Foundation New Scholar in Aging Award, Bill and Melinda Gates Grand Challenges Explorations Award, Linda Pechenik Montague Investigator Award, Sanofi Innovation Award, two Department of Defense Therapeutic Idea Awards, and the Michael S. Brown New Investigator Award, which recognizes faculty engaged in innovative discoveries.

Homepage: https://www.med.upenn.edu/shorterlab/People%20pages/jim.html

The Shorter Lab research aims to elucidate how to therapeutically counter deleterious protein misfolding in neurodegenerative diseases such as amyotrophic lateral schlerosis (ALS) synucleinopathies, Alzheimer’s disease, and Alzheimer’s Disease-Related Dementias (ADRDs). The Shorter Lab: https://www.med.upenn.edu/shorterlab/research.html